Dr. Martens plc (DRMTY)
OTCMKTS · Delayed Price · Currency is USD
1.089
+0.309 (39.62%)
At close: Apr 4, 2025

Dr. Martens Statistics

Total Valuation

Dr. Martens has a market cap or net worth of 672.28 million. The enterprise value is 1.14 billion.

Market Cap 672.28M
Enterprise Value 1.14B

Important Dates

The next estimated earnings date is Thursday, June 5, 2025.

Earnings Date Jun 5, 2025
Ex-Dividend Date Mar 7, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -4.20%
Shares Change (QoQ) -2.45%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 500.03M

Valuation Ratios

The trailing PE ratio is 17.06.

PE Ratio 17.06
Forward PE n/a
PS Ratio 0.62
PB Ratio 1.50
P/TBV Ratio 8.26
P/FCF Ratio 2.32
P/OCF Ratio 2.21
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.30, with an EV/FCF ratio of 3.95.

EV / Earnings 29.04
EV / Sales 1.07
EV / EBITDA 6.30
EV / EBIT 12.12
EV / FCF 3.95

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 1.34.

Current Ratio 2.26
Quick Ratio 0.98
Debt / Equity 1.34
Debt / EBITDA 3.29
Debt / FCF 2.08
Interest Coverage 2.28

Financial Efficiency

Return on equity (ROE) is 8.42% and return on invested capital (ROIC) is 5.32%.

Return on Equity (ROE) 8.42%
Return on Assets (ROA) 4.53%
Return on Invested Capital (ROIC) 5.32%
Return on Capital Employed (ROCE) 9.60%
Revenue Per Employee 410,703
Profits Per Employee 14,983
Employee Count 2,630
Asset Turnover 0.82
Inventory Turnover 0.99

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -56.09% in the last 52 weeks. The beta is 0.07, so Dr. Martens's price volatility has been lower than the market average.

Beta (5Y) 0.07
52-Week Price Change -56.09%
50-Day Moving Average 1.68
200-Day Moving Average n/a
Relative Strength Index (RSI) 42.15
Average Volume (20 Days) 1,084

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Dr. Martens had revenue of 1.08 billion and earned 39.40 million in profits. Earnings per share was 0.04.

Revenue 1.08B
Gross Profit 707.68M
Operating Income 95.16M
Pretax Income 51.60M
Net Income 39.40M
EBITDA 113.12M
EBIT 95.16M
Earnings Per Share (EPS) 0.04
Full Income Statement

Balance Sheet

The company has 127.19 million in cash and 602.73 million in debt, giving a net cash position of -475.54 million.

Cash & Cash Equivalents 127.19M
Total Debt 602.73M
Net Cash -475.54M
Net Cash Per Share n/a
Equity (Book Value) 448.33M
Book Value Per Share 0.47
Working Capital 325.96M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 303.85 million and capital expenditures -14.21 million, giving a free cash flow of 289.64 million.

Operating Cash Flow 303.85M
Capital Expenditures -14.21M
Free Cash Flow 289.64M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 65.52%, with operating and profit margins of 8.81% and 3.65%.

Gross Margin 65.52%
Operating Margin 8.81%
Pretax Margin 4.78%
Profit Margin 3.65%
EBITDA Margin 10.47%
EBIT Margin 8.81%
FCF Margin 26.81%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 3.74%.

Dividend Per Share 0.04
Dividend Yield 3.74%
Dividend Growth (YoY) -68.50%
Years of Dividend Growth n/a
Payout Ratio 51.02%
Buyback Yield 4.20%
Shareholder Yield 7.95%
Earnings Yield 5.86%
FCF Yield 43.08%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Dr. Martens has an Altman Z-Score of 4.86.

Altman Z-Score 4.86
Piotroski F-Score n/a